Investing

Nurix Therapeutics : NRIX

NRIX

Stock Data

$14.92

$0.36 (2.36%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Nurix Therapeutics Inc is a biopharmaceutical company in the clinical stage, dedicated to creating innovative treatments for cancer, inflammatory conditions, and other diseases. It focuses on developing small molecule and cell therapies, including a range of drugs aimed at combating B-cell malignancies and autoimmune diseases, as well as advancing immuno-oncology treatments. With strategic collaborations with industry giants like Gilead Sciences, Sanofi S.A., and Seagen Inc., Nurix is at the forefront of leveraging scientific breakthroughs to improve patient outcomes. Founded in 2009 and based in San Francisco, California, Nurix is committed to transforming the therapeutic landscape.

All Nurix Therapeutics Articles

1 Article

Trey Thoelcke | May 18, 2026 at 7:35 AM EDT

7 Healthcare AI Stocks Under $50 With Huge Upside Potential

Healthcare AI stocks have been hammered in 2026, with several names down 30% to 65% year to date even as…